Acotec Scientific Holdings Ltd. is a medical device technology platform company, which engages in research and development on providing treatment solutions for vascular diseases. The company is headquartered in Beijing, Beijing and currently employs 645 full-time employees. The company went IPO on 2021-08-24. The firm is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The firm conducts businesses within domestic and overseas markets.
06669.HK stock price ended at $14.66 on 星期五, after rising 2.88%
On the latest trading day Jan 16, 2026, the stock price of 06669.HK rose by 2.88%, climbing from $14.33 to $14.66. Throughout the session, the stock experienced a volatility of 3.02%, with prices fluctuating between a daily low of $14.25 and a high of $14.68. Alongside this price increase, trading volume also rose by 66.3K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 300.3K shares were traded, amounting to a market value of approximately $4.5B.